Literature DB >> 31434842

Acute and chronic effects of mokuboito in a patient with heart failure due to severe aortic regurgitation.

Eri Miho1, Masumi Iwai-Takano2, Hiromi Saitoh3, Tomoyuki Watanabe1.   

Abstract

Medical treatment for heart failure is still limited in patients with symptomatic aortic regurgitation (AR). Here we report the effects of mokuboito used in combination with standard medical therapy for heart failure in an inoperable patient with symptomatic severe AR. We observed acute effects of mokuboito in decreasing systemic vascular resistance and increasing cardiac output, as well as its chronic effects in improving New York Heart Association class, plasma brain natriuretic peptide levels, and left ventricular diastolic function. Given its efficacy, the use of mokuboito might be an additional treatment for patients with heart failure.

Entities:  

Keywords:  Kampo medicine; aortic regurgitation; cardiac afterload; heart failure; mokuboito; systemic vascular resistance

Mesh：

Substances：

Year:  2019        PMID： 31434842      PMCID： PMC6760917          DOI： 10.5387/fms.2019-05

Source DB:  PubMed          Journal:  Fukushima J Med Sci        ISSN： 0016-2590


  7 in total

1.  Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography.

Authors:  Miguel A Quiñones; Catherine M Otto; Marcus Stoddard; Alan Waggoner; William A Zoghbi
Journal:  J Am Soc Echocardiogr       Date:  2002-02       Impact factor: 5.251

2.  First report on 30-day and operative mortality in risk model of isolated coronary artery bypass grafting in Japan.

Authors:  Noboru Motomura; Hiroaki Miyata; Hiroyuki Tsukihara; Masafumi Okada; Shinichi Takamoto
Journal:  Ann Thorac Surg       Date:  2008-12       Impact factor: 4.330

3.  2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Rick A Nishimura; Catherine M Otto; Robert O Bonow; Blase A Carabello; John P Erwin; Lee A Fleisher; Hani Jneid; Michael J Mack; Christopher J McLeod; Patrick T O'Gara; Vera H Rigolin; Thoralf M Sundt; Annemarie Thompson
Journal:  J Am Coll Cardiol       Date:  2017-03-15       Impact factor: 24.094

4.  Repeated sauna treatment improves vascular endothelial and cardiac function in patients with chronic heart failure.

Authors:  Takashi Kihara; Sadatoshi Biro; Masakazu Imamura; Shiro Yoshifuku; Kunitsugu Takasaki; Yoshiyuki Ikeda; Yutaka Otuji; Shinichi Minagoe; Yoshifumi Toyama; Chuwa Tei
Journal:  J Am Coll Cardiol       Date:  2002-03-06       Impact factor: 24.094

5.  Optimal noninvasive assessment of diastolic heart failure in patients with atrial fibrillation: comparison of tissue doppler echocardiography, left atrium size, and brain natriuretic peptide.

Authors:  Tomoyuki Watanabe; Masumi Iwai-Takano; Masayoshi Oikawa; Takayoshi Yamaki; Hiroyuki Yaoita; Yukio Maruyama
Journal:  J Am Soc Echocardiogr       Date:  2007-09-29       Impact factor: 5.251

6.  Acute hemodynamic improvement by thermal vasodilation in congestive heart failure.

Authors:  C Tei; Y Horikiri; J C Park; J W Jeong; K S Chang; Y Toyama; N Tanaka
Journal:  Circulation       Date:  1995-05-15       Impact factor: 29.690

7.  Vascular pharmacology of mokuboito (mu-fang-yi-tang) and its constituents on the smooth muscle and the endothelium in rat aorta.

Authors:  Seiichiro Nishida; Hiroyasu Satoh
Journal:  Evid Based Complement Alternat Med       Date:  2007-09       Impact factor: 2.629
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.